Highland Capital Management LLC Raises Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Highland Capital Management LLC increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 10.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,509 shares of the exchange traded fund’s stock after buying an additional 2,404 shares during the quarter. Highland Capital Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,297,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in XBI. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after acquiring an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new stake in SPDR S&P Biotech ETF during the 3rd quarter worth about $141,284,000. Mirae Asset Securities USA Inc. raised its stake in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after buying an additional 300,000 shares during the last quarter. Assetmark Inc. lifted its holdings in shares of SPDR S&P Biotech ETF by 72,653.0% in the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock valued at $58,223,000 after buying an additional 588,489 shares during the period. Finally, Whittier Trust Co. boosted its stake in shares of SPDR S&P Biotech ETF by 3.3% in the third quarter. Whittier Trust Co. now owns 311,027 shares of the exchange traded fund’s stock worth $30,729,000 after buying an additional 9,976 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.0 %

Shares of XBI stock opened at $93.54 on Friday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock has a market cap of $7.13 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock has a 50 day moving average of $93.31 and a 200 day moving average of $96.77.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.